News
I jotted notes for this update as I flew back from the Partnership Opportunities for Drug Delivery (PODD) conference in Boston. CRS was well represented at this conference. The conference, now in its fourth year, was again chaired by Board of Scientific Advisors (BSA) member Barbara Lueckel.…
Samir Mitragotri is a prominent leader in the field of drug delivery and biomaterials. His contribution in the field of transdermal drug delivery was noticed by the community when his group successfully published the delivery of vaccines (proteins), insulin (peptides), and siRNA via skin into the…
We are well into the new academic year and—for those of us in the Northern hemisphere—packing up all our memories from hopefully a wonderful summer.
Teaching is on my mind at this time, in particular an awareness of the increasing numbers of distance education programs and institutions offering…
Mauro Ferrari is the executive vice president of Houston Methodist Hospital (a U.S. News and World Report Honor Roll Hospital, 2016) and the president/CEO of the
Mauro Ferrari in front of the Houston Methodist Research Institute he inaugurated in 2011.Houston Methodist Research Institute, where he…
Introduction
Overexpression of cyclooxegenase-2 (COX-2) is a hallmark of inflammation and an early event in carcinogenesis and cancer progression.1,2 Because COX-2 is expressed in virtually all solid tumors, it represents an ideal biomarker with broad impact for the early clinical detection of…
Vinod LabhasetwarAt the DDTR editorial board meeting held during the CRS annual meeting in Seattle, I updated several parameters related to the journal and presented my vision for further growth. The most significant news was a 130% increase in citations compared with the year ending July 2015.…
